Section 71 & 15 – ACCEPTED AND ACKNOWLEDGED
on 29 Jun 2022
Last Applicant/ Owned by
Dundee Technology Park
Dundee
GB
DD2 1XA
Serial Number
79085615 filed on 14th Jun 2010
Registration Number
4085678 registered on 17th Jan 2012
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
AXIS-SHIELD INNOVATION FOR LIFE
Medical diagnostic apparatus and instruments, all for sale in kit form, namely, multiassay analysers, reagent cartridges, sampling devices, blood sampling devices, assay analysers, blood analysers, serum analysers, plasma analysers, urine sampling devices, urine analysers, membrane tubes, capillaries, microtitre plates, microtitre strips and pipettes; apparatus for use in the diagnosis of ailments Read More
Classification Information
Class [010]
Medical Instrument Products
Medical diagnostic apparatus and instruments, all for sale in kit form, namely, multiassay analysers, reagent cartridges, sampling devices, blood sampling devices, assay analysers, blood analysers, serum analysers, plasma analysers, urine sampling devices, urine analysers, membrane tubes, capillaries, microtitre plates, microtitre strips and pipettes; apparatus for use in the diagnosis of ailments, namely, multiassay analysers, assay analysers, blood analysers, serum analysers, plasma analysers, urine sampling devices, urine analysers, reagent cartridges, sampling devices, blood sampling devices, urine sampling devices, membrane tubes, capillaries, microtitre plates, microtitre strips and pipettes; and structural or replacement parts and fittings for all the aforesaid goods
Class [005]
Pharmaceutical Products
Chemical reagents and preparations for medical purposes, for treating or diagnosing critical illnesses in the nature of diabetes, diabetic renal, cardiovascular and neurodegenerative diseases, rheumatoid arthritis, deep vein thrombosis, pulmonary embolisms, vitamin deficiencies, bacterial or viral infections, including sepsis, inflammation, and anticoagulation monitoring; chemical reagents and preparations for medical use, for diagnostic purposes; diagnostic preparations for medical purposes; diagnostic preparations for medical use, for sale in kit form, consisting of two or more of conjugates, membrane tubes, washing solutions, reagents, reconstitution reagents, precipitation agents, stabilised human whole blood, stabilised porcine whole blood, citrate buffers, substrates, stop solutions, wash buffers, diluents, human plasma, human serum, control solutions, dilution liquids and dilution buffers; diagnostic preparations and reagents for medical purposes, for in-vitro use; diagnostic kits for medical use, consisting primarily of reagents; chemical preparations for laboratory use, for medical purposes, for use in treating or diagnosing critical illnesses in the nature of diabetes, diabetic renal, cardiovascular and neurodegenerative diseases, rheumatoid arthritis, deep vein thrombosis, pulmonary embolisms, vitamin deficiencies, bacterial or viral infections, including sepsis, inflammation, and anticoagulation monitoring; medical diagnostic reagents for biological and chemical assays
Class [001]
Chemical Products
Diagnostic preparations for scientific use, for the detection of bacteria and antibodies to said bacteria
Mark Details
Serial Number
No 79085615
Mark Type
No Service/Collective Mark
Attorney Docket Number
No GRN 6045823
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 08th Dec 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| 29th Jun 2022 | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. |
| 29th Jun 2022 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED |
| 22nd Jun 2022 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 18th Jan 2022 | TEAS SECTION 71 & 15 RECEIVED |
| 17th Jan 2021 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED |
| 02th Jul 2020 | INTERNATIONAL REGISTRATION RENEWED |
| 22nd Jun 2018 | NEW REPRESENTATIVE AT IB RECEIVED |
| 21st Dec 2017 | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. |
| 21st Dec 2017 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED |